Oppenheimer Assumes Everus (ECG) at Outperform

May 28, 2026 4:03 AM

Oppenheimer analyst Brent Thielman assumes coverage on Everus (NYSE: ECG) with a Outperform rating and a price target of $185.00.The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found